IPO - Neuronetics, Inc.

Form Type: 8-K

Filing Date: 2025-02-10

Corporate Action: Ipo

Type: New

Accession Number: 000119312525022833

Filing Summary: On February 7, 2025, Neuronetics, Inc. entered into an Underwriting Agreement with Canaccord Genuity LLC to issue and sell 8,000,000 shares of common stock at a public offering price of $2.25 per share. The Underwriter has an option to purchase an additional 1,200,000 shares within 30 days of the agreement. The offering is expected to close on February 10, 2025, and net proceeds are estimated to be approximately $16.355 million, or $18.893 million if the additional shares are purchased. Proceeds will be used for general corporate purposes, including sales and marketing, research and development, financing potential acquisitions, inventory purchases, and working capital. The offering is made under a prospectus supplement filed with the SEC.

Document Link: View Document